Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Abstract
Both long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS) have been recommended in guidelines for the treatment of chronic obstructive pulmonary disease (COPD). Their coadministration in a combination inhaler may facilitate adherence to medication regimens and improve efficacy.To determine the efficacy and safety of combined ICS and LABA for stable COPD in comparison with placebo.We searched the Cochrane Airways Group Specialised...
Paper Details
Title
Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Published Date
Nov 10, 2013
Journal
Volume
2018
Issue
3
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History